# A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

> **NCT00105040** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 87 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Levetiracetam
- **OTHER:** Placebo (PB)

## Key facts

- **NCT ID:** NCT00105040
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2015-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105040, "A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00105040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*